Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA 22352 |
|---|---|
| 2: Name of authorisation holder | VERTEX PHARMACEUTICALS (EUROPE) LIMITED |
| 3: Address(es) of manufacturing site(s) |
VERTEX PHARMACEUTICALS (EUROPE) LIMITED, LEVEL 9, PADDINGTON CENTRAL, 2 KINGDOM STREET, LONDON, W2 6BD, UNITED KINGDOM |
| 4: Legally registered address of authorisation holder | VERTEX PHARMACEUTICALS (EUROPE) LIMITED, LEVEL 9, PADDINGTON CENTRAL, 2 KINGDOM STREET, LONDON, W2 6BD, UNITED KINGDOM |
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
| 8: Authorisation Date | 08/10/2024 |
| 9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 1
Name and address of the site:
VERTEX PHARMACEUTICALS (EUROPE) LIMITED, LEVEL 9, PADDINGTON CENTRAL, 2 KINGDOM STREET, LONDON, W2 6BD, UNITED KINGDOM
Human Medicinal Products
| Authorised Operations |
| MANUFACTURING OPERATIONS (according to part 1)IMPORTATION OF MEDICINAL PRODUCTS (according to part 2) |
| Part 1 - MANUFACTURING OPERATIONS |
| [ 1.3 ] Biological medicinal products |
| [ 1.3.2 ] Batch certification |
| [ 1.3.2.3 ] Cell therapy products |
| [ 1.3.2.4 ] Gene therapy products |
| Part 2 - IMPORTATION OF MEDICINAL PRODUCTS |
| [ 2.2 ] Batch certification of imported medicinal products |
| [ 2.2.3 ] Biological medicinal products |
| [ 2.2.3.3 ] Cell therapy products |
| [ 2.2.3.4 ] Gene therapy products |
| [ 2.3 ] Other Importation Activities |
| [ 2.3.4 ] Products authorised under regulation 174 (supply in response to spread of pathogenic agents etc) Importation of Autologous drug product into Authorised Treatment Centers in the UK |